_id
69171b183c536f8df23165f5
Ticker
SYVC
Name
Synovics Pharmaceuticals Inc
Exchange
OTCCE
Address
5360 Northwest 35th Avenue, Fort Lauderdale, FL, United States, 33309
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
Description
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-07T12:45:58.588Z
Image
data:image/webp;base64,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
Ipo Date
1997-10-22T00:00:00.000Z
Market Cap
542858
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2009-07-31
Revenue
1578332
Cost Of Revenue
2158091
Gross Profit
-579759
Operating Expenses
3437362
Operating Income
-1859030
Interest Expense
163308
Pretax Income
-2020887
Net Income
-2020887
Eps
-
Dividends Per Share
-
Shares Outstanding
29827357
Income Tax Expense
-
EBITDA
-
Operating Margin
-117.78447120124282
Total Other Income Expense Net
-161857
Cash
129860
Short Term Investments
-
Receivables
1543381
Inventories
2319184
Total Current Assets
4676398
Property Plant Equipment
2199730
Total Assets
18767220
Payables
7543739
Short Term Debt
2400000
Long Term Debt
1700000
Total Liabilities
19540253
Equity
-1600986
Bs_currency_symbol
USD
Depreciation
215407
Change In Working Capital
-
Cash From Operations
60697
Capital Expenditures
43075
Cash From Investing
-43075
Cash From Financing
102955
Net Change In Cash
120577
Cf_currency_symbol
USD
PE
-
PB
-
ROE
126.22764971086569
ROA
-10.768174508531365
FCF
17622
Fcf Percent
0.011164951353707585
Piotroski FScore
2
Health Score
41
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
4
Growth Investing Score
4
Momentum Investing Score
4
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
3
Quarters > 0 > quarter
2009-07-31
Quarters > 0 > income Statement > revenue
1578332
Quarters > 0 > income Statement > cost Of Revenue
2158091
Quarters > 0 > income Statement > gross Profit
-579759
Quarters > 0 > income Statement > operating Expenses
3437362
Quarters > 0 > income Statement > operating Income
-1859030
Quarters > 0 > income Statement > interest Expense
163308
Quarters > 0 > income Statement > pretax Income
-2020887
Quarters > 0 > income Statement > net Income
-2020887
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-117.78447120124282
Quarters > 0 > income Statement > total Other Income Expense Net
-161857
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
129860
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1543381
Quarters > 0 > balance Sheet > inventories
2319184
Quarters > 0 > balance Sheet > total Current Assets
4676398
Quarters > 0 > balance Sheet > property Plant Equipment
2199730
Quarters > 0 > balance Sheet > total Assets
18767220
Quarters > 0 > balance Sheet > payables
7543739
Quarters > 0 > balance Sheet > short Term Debt
2400000
Quarters > 0 > balance Sheet > long Term Debt
1700000
Quarters > 0 > balance Sheet > total Liabilities
19540253
Quarters > 0 > balance Sheet > equity
-1600986
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2020887
Quarters > 0 > cash Flow > depreciation
215407
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
60697
Quarters > 0 > cash Flow > capital Expenditures
43075
Quarters > 0 > cash Flow > cash From Investing
-43075
Quarters > 0 > cash Flow > cash From Financing
102955
Quarters > 0 > cash Flow > net Change In Cash
120577
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
126.22764971086569
Quarters > 0 > ratios > ROA
-10.768174508531365
Quarters > 0 > ratios > FCF
17622
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.011164951353707585
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2009-04-30
Quarters > 1 > income Statement > revenue
2809430
Quarters > 1 > income Statement > cost Of Revenue
2781561
Quarters > 1 > income Statement > gross Profit
27869
Quarters > 1 > income Statement > operating Expenses
4899851
Quarters > 1 > income Statement > operating Income
-2090421
Quarters > 1 > income Statement > interest Expense
502196
Quarters > 1 > income Statement > pretax Income
-2592618
Quarters > 1 > income Statement > net Income
-2592618
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-74.4072997013629
Quarters > 1 > income Statement > total Other Income Expense Net
-502197
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9283
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2529228
Quarters > 1 > balance Sheet > inventories
2103361
Quarters > 1 > balance Sheet > total Current Assets
5134320
Quarters > 1 > balance Sheet > property Plant Equipment
2324392
Quarters > 1 > balance Sheet > total Assets
19434205
Quarters > 1 > balance Sheet > payables
7187265
Quarters > 1 > balance Sheet > short Term Debt
2900000
Quarters > 1 > balance Sheet > long Term Debt
2300000
Quarters > 1 > balance Sheet > total Liabilities
18094364
Quarters > 1 > balance Sheet > equity
511888
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2592618
Quarters > 1 > cash Flow > depreciation
130864
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
88054
Quarters > 1 > cash Flow > capital Expenditures
1809
Quarters > 1 > cash Flow > cash From Investing
1809
Quarters > 1 > cash Flow > cash From Financing
-100198
Quarters > 1 > cash Flow > net Change In Cash
-10335
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-506.4814959522396
Quarters > 1 > ratios > ROA
-13.340489101560882
Quarters > 1 > ratios > FCF
86245
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.03069839789565855
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2009-01-31
Quarters > 2 > income Statement > revenue
6836279
Quarters > 2 > income Statement > cost Of Revenue
4495019
Quarters > 2 > income Statement > gross Profit
2341260
Quarters > 2 > income Statement > operating Expenses
7470093
Quarters > 2 > income Statement > operating Income
-633814
Quarters > 2 > income Statement > interest Expense
467239
Quarters > 2 > income Statement > pretax Income
-1101054
Quarters > 2 > income Statement > net Income
-1101054
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-9.27133020755882
Quarters > 2 > income Statement > total Other Income Expense Net
-467240
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
19618
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3763558
Quarters > 2 > balance Sheet > inventories
2635466
Quarters > 2 > balance Sheet > total Current Assets
7044427
Quarters > 2 > balance Sheet > property Plant Equipment
2409396
Quarters > 2 > balance Sheet > total Assets
21778388
Quarters > 2 > balance Sheet > payables
6965131
Quarters > 2 > balance Sheet > short Term Debt
2200000
Quarters > 2 > balance Sheet > long Term Debt
3000000
Quarters > 2 > balance Sheet > total Liabilities
17740630
Quarters > 2 > balance Sheet > equity
3209805
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1101054
Quarters > 2 > cash Flow > depreciation
155367
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
593022
Quarters > 2 > cash Flow > capital Expenditures
49406
Quarters > 2 > cash Flow > cash From Investing
-49406
Quarters > 2 > cash Flow > cash From Financing
-589984
Quarters > 2 > cash Flow > net Change In Cash
-46368
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-34.302831480417034
Quarters > 2 > ratios > ROA
-5.055718540784562
Quarters > 2 > ratios > FCF
543616
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.07951928234643436
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2008-10-31
Quarters > 3 > income Statement > revenue
7867457
Quarters > 3 > income Statement > cost Of Revenue
5191816
Quarters > 3 > income Statement > gross Profit
2675641
Quarters > 3 > income Statement > operating Expenses
7601938
Quarters > 3 > income Statement > operating Income
265519
Quarters > 3 > income Statement > interest Expense
467239
Quarters > 3 > income Statement > pretax Income
670327
Quarters > 3 > income Statement > net Income
670327
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
3.3749024621297576
Quarters > 3 > income Statement > total Other Income Expense Net
404808
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
65986
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3820465
Quarters > 3 > balance Sheet > inventories
2901664
Quarters > 3 > balance Sheet > total Current Assets
7165384
Quarters > 3 > balance Sheet > property Plant Equipment
2483577
Quarters > 3 > balance Sheet > total Assets
22346110
Quarters > 3 > balance Sheet > payables
5978002
Quarters > 3 > balance Sheet > short Term Debt
2100000
Quarters > 3 > balance Sheet > long Term Debt
3550000
Quarters > 3 > balance Sheet > total Liabilities
17344616
Quarters > 3 > balance Sheet > equity
4173541
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
670327
Quarters > 3 > cash Flow > depreciation
172478
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
1245454
Quarters > 3 > cash Flow > capital Expenditures
122244
Quarters > 3 > cash Flow > cash From Investing
-122244
Quarters > 3 > cash Flow > cash From Financing
-1483284
Quarters > 3 > cash Flow > net Change In Cash
-360073
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
16.061349343399286
Quarters > 3 > ratios > ROA
2.999748054583102
Quarters > 3 > ratios > FCF
1123210
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.14276658900074066
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2008-10-31
Annuals > 0 > income Statement > revenue
25959579
Annuals > 0 > income Statement > cost Of Revenue
16988322
Annuals > 0 > income Statement > gross Profit
8971257
Annuals > 0 > income Statement > operating Expenses
28443044
Annuals > 0 > income Statement > operating Income
-2483465
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-4005831
Annuals > 0 > income Statement > net Income
-4005831
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-9.566661308336318
Annuals > 0 > income Statement > total Other Income Expense Net
-1522366
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
65986
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3820465
Annuals > 0 > balance Sheet > inventories
2901664
Annuals > 0 > balance Sheet > total Current Assets
7165384
Annuals > 0 > balance Sheet > property Plant Equipment
2483577
Annuals > 0 > balance Sheet > total Assets
22346110
Annuals > 0 > balance Sheet > payables
5978002
Annuals > 0 > balance Sheet > short Term Debt
2100000
Annuals > 0 > balance Sheet > long Term Debt
3550000
Annuals > 0 > balance Sheet > total Liabilities
17344616
Annuals > 0 > balance Sheet > equity
4173541
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-4005831
Annuals > 0 > cash Flow > depreciation
611360
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
3862575
Annuals > 0 > cash Flow > capital Expenditures
708305
Annuals > 0 > cash Flow > cash From Investing
-708305
Annuals > 0 > cash Flow > cash From Financing
-3088284
Annuals > 0 > cash Flow > net Change In Cash
65986
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-95.98158973399326
Annuals > 0 > ratios > ROA
-17.926301266752915
Annuals > 0 > ratios > FCF
3154270
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.121506978214092
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2007-10-31
Annuals > 1 > income Statement > revenue
23466311
Annuals > 1 > income Statement > cost Of Revenue
16837126
Annuals > 1 > income Statement > gross Profit
6629185
Annuals > 1 > income Statement > operating Expenses
33730782
Annuals > 1 > income Statement > operating Income
-10264471
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-20857884
Annuals > 1 > income Statement > net Income
-20857884
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-43.74130642008452
Annuals > 1 > income Statement > total Other Income Expense Net
-10593413
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3328951
Annuals > 1 > balance Sheet > inventories
1928009
Annuals > 1 > balance Sheet > total Current Assets
5559897
Annuals > 1 > balance Sheet > property Plant Equipment
2024407
Annuals > 1 > balance Sheet > total Assets
23333897
Annuals > 1 > balance Sheet > payables
4716702
Annuals > 1 > balance Sheet > short Term Debt
4695000
Annuals > 1 > balance Sheet > long Term Debt
5450000
Annuals > 1 > balance Sheet > total Liabilities
31438023
Annuals > 1 > balance Sheet > equity
-8903124
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-20857884
Annuals > 1 > cash Flow > depreciation
596634
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-2408514
Annuals > 1 > cash Flow > capital Expenditures
709593
Annuals > 1 > cash Flow > cash From Investing
-709593
Annuals > 1 > cash Flow > cash From Financing
724670
Annuals > 1 > cash Flow > net Change In Cash
-2393437
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
234.27601367789555
Annuals > 1 > ratios > ROA
-89.38877205123516
Annuals > 1 > ratios > FCF
-3118107
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.13287589174114328
Annuals > 1 > health Score
41
Annuals > 2 > quarter
2006-10-31
Annuals > 2 > income Statement > revenue
10516398
Annuals > 2 > income Statement > cost Of Revenue
8158727
Annuals > 2 > income Statement > gross Profit
2357671
Annuals > 2 > income Statement > operating Expenses
14135584
Annuals > 2 > income Statement > operating Income
-3619186
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-7528902
Annuals > 2 > income Statement > net Income
-8571021
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-34.41469217882396
Annuals > 2 > income Statement > total Other Income Expense Net
-3909716
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2393437
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2037860
Annuals > 2 > balance Sheet > inventories
2376480
Annuals > 2 > balance Sheet > total Current Assets
7730447
Annuals > 2 > balance Sheet > property Plant Equipment
1642282
Annuals > 2 > balance Sheet > total Assets
38882650
Annuals > 2 > balance Sheet > payables
3226664
Annuals > 2 > balance Sheet > short Term Debt
6087047
Annuals > 2 > balance Sheet > long Term Debt
11500000
Annuals > 2 > balance Sheet > total Liabilities
25779163
Annuals > 2 > balance Sheet > equity
12304489
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-8571021
Annuals > 2 > cash Flow > depreciation
122911
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-5165425
Annuals > 2 > cash Flow > capital Expenditures
447939
Annuals > 2 > cash Flow > cash From Investing
-10392751
Annuals > 2 > cash Flow > cash From Financing
17822794
Annuals > 2 > cash Flow > net Change In Cash
2264618
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-69.65767534108893
Annuals > 2 > ratios > ROA
-22.04330466159071
Annuals > 2 > ratios > FCF
-5613364
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.5337724951071651
Annuals > 2 > health Score
21
Annuals > 3 > quarter
2005-10-31
Annuals > 3 > income Statement > revenue
8192
Annuals > 3 > income Statement > cost Of Revenue
45289
Annuals > 3 > income Statement > gross Profit
-37097
Annuals > 3 > income Statement > operating Expenses
1919757
Annuals > 3 > income Statement > operating Income
-1911565
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-2690846
Annuals > 3 > income Statement > net Income
-2911260
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-23334.53369140625
Annuals > 3 > income Statement > total Other Income Expense Net
-779281
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
128819
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
4010
Annuals > 3 > balance Sheet > total Current Assets
270438
Annuals > 3 > balance Sheet > property Plant Equipment
4513
Annuals > 3 > balance Sheet > total Assets
16911555
Annuals > 3 > balance Sheet > payables
1007570
Annuals > 3 > balance Sheet > short Term Debt
1423980
Annuals > 3 > balance Sheet > long Term Debt
1424000
Annuals > 3 > balance Sheet > total Liabilities
5607804
Annuals > 3 > balance Sheet > equity
10504753
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2911260
Annuals > 3 > cash Flow > depreciation
32015
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-2258086
Annuals > 3 > cash Flow > capital Expenditures
237809
Annuals > 3 > cash Flow > cash From Investing
-350056
Annuals > 3 > cash Flow > cash From Financing
2107704
Annuals > 3 > cash Flow > net Change In Cash
-500438
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-27.71374062769491
Annuals > 3 > ratios > ROA
-17.21462041781492
Annuals > 3 > ratios > FCF
-2495895
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-304.6746826171875
Annuals > 3 > health Score
31
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
126.22764971086569
Profitability > metrics > ROA
-43.21460662672425
Profitability > metrics > Net Margin
-1.2803941122653535
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-11.383581943321822
Risk > final Score
-16
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.4702856742317955
Liquidity > metrics > Quick Ratio
0.2370550956737702
Liquidity > final Score
22
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
73
Prev Risks > 0
-11
Prev Risks > 1
1
Prev Risks > 2
8
Prev Liquidities > 0
25
Prev Liquidities > 1
34
Prev Liquidities > 2
36
Updated At
2026-01-20T22:39:49.072Z
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A7 Best Furniture Inventory Management Software for 2026 (Reviewed) Shopify
Read more →Showing 2 of 9
(Last Updated 2009-07-31)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Synovics Pharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2009-07-31)
(Last Updated 2009-07-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2009-07-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2009-07-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.